Exocrine Pancreatic Insufficiency

Ultrasounds Help Identify Advanced Cystic Fibrosis Liver Disease

February 29, 2020

Article

Advanced cystic fibrosis liver disease manifests as portal hypertension with or without cirrhosis in about 7% of patients with cystic fibrosis.

Cannabis Users With Acute Pancreatitis Less Likely to Have Necrosis, Fluid Collections

October 31, 2019

Article

In a pioneer study, investigators investigate if cannabis users had less incidence of pancreatic necrosis and/or pancreatic/peripancreatic fluid collections.

Roberto Simons-Linares, MD: How a Hepatitis Viral Infection Causes Acute Pancreatitis

October 30, 2019

Article

Roberto Simons-Linares, MD, presents new data at the annual ACG meeting on the association between hepatitis viral infections and acute pancreatitis.

Roberto Simons-Linares, MD: The Impact of Cannabis Use for Acute Necrotizing Pancreatitis

October 29, 2019

Article

During the annual ACG meeting, Roberto Simons-Linares, MD explained how cannabis use impacts the fluids of patients suffering from acute necrotizing pancreatitis.

FDA Approves Triple Therapy to Treat Cystic Fibrosis

October 21, 2019

Article

The newly approved drug is a combination of 3 drugs that target the most common cystic fibrosis mutation.

FDA Approves Symdeko Tablets for Ages 6 and Older

June 21, 2019

Article

The FDA had previously only certified Symdeko tablets for treatment of children aged 12 years and older.

Catastrophizing and Cystic Fibrosis: Fear of Breathlessness Impacts Quality of Life

October 15, 2018

Article

Results connecting breathlessness catastrophizing with reduced quality of life also have implications for populations with asthma or COPD.

Antibiotics for CF Lung Infections Influenced by Oxygen, pH

October 02, 2018

Article

Upon finding pH and oxygen may influence how antibiotics perform in CF lung infections, investigators suggest a one-size-fits-all therapy approach may not be the best treatment.

Telavancin: Promising Treatment Option for MRSA in Cystic Fibrosis Patients?

September 10, 2018

Article

Investigators find telavancin has potent in vitro activity and low resistance development potential when used against S aureus isolates in patients with cystic fibrosis.

Top 5 Rare Disease News of the Week—August 12, 2018

August 18, 2018

Article

Stay up-to-date on the latest rare disease news by reading the top 5 articles of the week.

x